L-HOMOCYSTEINE CAS#: 6027-13-0; ChemWhat Code: 92081

IdentificationPhysical DataSpectra
Route of Synthesis (ROS)Safety and HazardsOther Data

Identification

Product NameL-HOMOCYSTEINE
IUPAC Name(2S)-2-amino-4-sulfanylbutanoic acid
Molecular Structure
CAS Registry Number 6027-13-0
EINECS Number227-891-0
MDL NumberMFCD00151320
Beilstein Registry NumberNo data available
SynonymsL-Homocysteine [ACD/Index Name];(2S)-2-amino-4-sulfanylbutanoic acid;(S)-2-amino-4-mercapto-Butanoic acid;(S)-2-Amino-4-mercaptobutanoic acid;(S)-2-Amino-4-mercaptobutyric acid;(S)-Homocysteine;Homocysteine, L-;L-Homocystein;(2S)-2-amino-4-mercaptobutanoic acid;(2S)-2-amino-4-mercapto-butyric acid; (2S)-2-amino-4-sulfanyl-butanoic acid;(2S)-2-ammonio-4-mercaptobutanoate;(2S)-2-azaniumyl-4-sulfanylbutanoate;
CAS#: 6027-13-0
CAS Number: 6027-13-0
Molecular FormulaC4H9NO2S
Molecular Weight135.185 
InChIInChI=1S/C4H9NO2S/c5-3(1-2-8)4(6)7/h3,8H,1-2,5H2,(H,6,7)/t3-/m0/s1
InChI KeyFFFHZYDWPBMWHY-VKHMYHEASA-N
Canonical SMILESC(CS)C(C(=O)O)N
Patent Information
Patent IDTitlePublication Date
US2012/148633 BINARY AND TERTIARY GALVANIC PARTICULATES AND METHODS OF MANUFACTURING AND USE THEREOF 2012

Physical Data

AppearanceSolid
SolubilityNo data available
Flash PointNo data available
Refractive index1.5480 (estimate)
SensitivityNo data available
Melting Point, °C Comment (Melting Point)
247 – 249 Decomposition
245 – 247 Decomposition
Description (Association (MCS))Solvent (Association (MCS))Comment (Association (MCS)) Partner (Association (MCS))
Association with compound aq. phosphate buffer C38H32N2O2S*Cu(2+)
Association with compound aq. phosphate buffer C38H32N2O2S*Cu(2+)
Association with compound C26H18N4O7S
Association with compound aq. buffer Hg+2 complex of supramolecular polymer with N,N’-di-(phenyl-3,5-dicarboxylic acid)-perylene-3,4:9,10-tetracarboxylic diimide and melamine
Association with compound water, acetonitrilecopper(II) ion
NMR spectrum of the complex3-(4-dimethylamino-phenyl)-propenal
UV/VIS spectrum of the complex in the presence of inorganic compounds fluorone black

Spectra

Description (NMR Spectroscopy)Nucleus (NMR Spectroscopy)Solvents (NMR Spectroscopy)Frequency (NMR Spectroscopy), MHz
Chemical shifts 1Hwater-d2 400
Chemical shifts 13Cwater-d2 101
Chemical shifts 1H300.1
Chemical shifts 13C75.5
Spectrum tetradeuteriomethanol, D2O
D2O 270
Chemical shifts 13CD2O, NaOH
Spin-lattice relaxation time (T1)
Description (IR Spectroscopy)Solvent (IR Spectroscopy)
Intensity of IR bands, Bands potassium bromide
Bands KBr
IR
Description (Mass Spectrometry)
liquid chromatography mass spectrometry (LCMS), time-of-flight mass spectra (TOFMS), spectrum
liquid chromatography mass spectrometry (LCMS), electrospray ionisation (ESI), time-of-flight mass spectra (TOFMS), spectrum
liquid chromatography mass spectrometry (LCMS), time-of-flight mass spectra (TOFMS), electrospray ionisation (ESI), high resolution mass spectrometry (HRMS), spectrum
electrospray ionisation (ESI), spectrum
liquid chromatography mass spectrometry (LCMS), tandem mass spectrometry, electrospray ionisation (ESI), spectrum
spectrum, tandem mass spectrometry, fragmentation pattern
Description (UV/VIS Spectroscopy)Solvent (UV/VIS Spectroscopy)
Spectrum dimethyl sulfoxide, water
Emission spectrum, Spectrum dimethyl sulfoxide, water
Spectrum aq. phosphate buffer

Route of Synthesis (ROS)

Route of Synthesis (ROS) of L-HOMOCYSTEINE CAS 6027-13-0
Route of Synthesis (ROS) of L-HOMOCYSTEINE CAS 6027-13-0
ConditionsYield
With hydrogen In ethyl acetate at 20℃; under 7600.51 Torr; for 6h; Autoclave;99%
With 0.2C27H36N2*Pt; hydrogen In tetrahydrofuran at 60℃; under 3000.3 Torr; for 5h; chemoselective reaction;99%
With hydrogen In ethyl acetate under 760.051 Torr; for 2h; Heating; Flow reactor; Green chemistry;99%
With hydrogen; triethylamine In ethanol; water at 110℃; under 30003 Torr; for 24h; Autoclave;98%
With hydrogen In 2-methyltetrahydrofuran; water at 40℃; under 15001.5 Torr; for 24h; chemoselective reaction;98%
With sodium tetrahydroborate In water at 20℃; for 1.5h; chemoselective reaction;

Experimental Procedure
General procedure: In a typical experiment, 0.5mmol of nitroarene and 0.002g(2mol%) NiNPs/DNA were added to 2mL water and thenstirred for 2-3min for thoroughly mixing. Subsequently,1mmol of NaBH4was added to the reaction mixture undermagnetic stirring at room temperature. The extent of thereaction was monitored by thin layer chromatography.Reproducibility of the results was checked by repeating theruns at least three times and was found to be within acceptablelimits (± 3%). When the reaction was completed, thereaction mixture was diluted with ethyl acetate and the catalystwas recovered by centrifugation. The combined organicfractions were dried over Na2SO4and evaporated underreduced pressure. The crude product was purified by columnchromatography on silica gel with a mixture of ethyl acetateand n-hexane as the eluent, and the ratio of ethyl acetate andn-hexane was depended on the structure of the products.The structure of isolated products was verified by 1H NMR.
97%

Safety and Hazards

Pictogram(s)exclamation-mark
SignalWarning
GHS Hazard StatementsH302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
Information may vary between notifications depending on impurities, additives, and other factors.
Precautionary Statement CodesP264, P270, P301+P312, P330, and P501
(The corresponding statement to each P-code can be found at the GHS Classification page.)

Other Data

TransportationNONH for all modes of transport
Under the room temperature and away from light
HS Code2930909
StorageUnder the room temperature and away from light
Shelf LifeNo data available
Market PriceUSD
Use Pattern
Cosmetics/dental/toilet
Food/food additives
L-HOMOCYSTEINE CAS#: 6027-13-0 as Pharmaceuticals
agent for inhibiting epidermal hyperplasia caused by exposure to ultraviolet light
cosmetics for inhibiting epidermal hyperplasia caused by exposure to ultraviolet light
drink for inhibiting epidermal hyperplasia caused by exposure to ultraviolet light
medicine for inhibiting epidermal hyperplasia caused by exposure to ultraviolet light
quasi-drug for inhibiting epidermal hyperplasia caused by exposure to ultraviolet light
combination with boronic acid compound in treating a bacterial infection
Component for pharmaceutical compositions for treatment of skin disease

Buy Reagent

No reagent supplier? Send quick inquiry to ChemWhat
Want to be listed here as a reagent supplier? (Paid service) Click here to contact ChemWhat

Approved Manufacturers

Ulcho Biochemical Ltdhttp://www.ulcho.com/
Want to be listed as an approved manufacturer (Requires approvement)? Please download and fill out this form and send back to approved-manufacturers@chemwhat.com

Contact Us for Other Help

Contact us for other information or services Click here to contact ChemWhat